January 19, 2025 02:22 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Kolkata court convicts civic volunteer Sanjoy Roy in RG Kar rape-murder case | Saif was stabbed repeatedly, he tried to protect Taimur and Jeh: Kareena Kapoor Khan records statement with police | Escaped death by 20-25 minutes: Sheikh Hasina alleges opposition wanted to kill her | Cabinet's decision on 8th Pay Commission will improve quality of life, give boost to consumption: PM Modi | 'It has been an incredibly challenging day': Kareena Kapoor Khan requests privacy after Saif Ali Khan's stabbing incident | 'Distorting history': Mamata slams Mohan Bhagwat over his Ram Temple consecration 'marking true independence' remark | Saif Ali Khan stabbing incident: Actor who received six wounds is out of danger, one accused identified | ISRO creates history docking two Indian satellites in space | US-based short seller Hindenburg Research that targeted Adani Group and SEBI chairperson to be disbanded | Saif Ali Khan stabbed during burglary attempt at home, hospitalised; police probe on
Coronavirus Vaccine

Covid vaccine approval likely soon : DCGI

| @indiablooms | Dec 31, 2020, at 11:29 pm

New Delhi/IBNS: The coronavirus vaccines awaiting approval can be cleared soon, India's drug control authority said Thursday.

Drugs Controller General Dr VG Somani said today in a webinar that probably there will be "a happy new year with something in hand".

Somani's assurance came a day ahead of the crucial meeting of the expert panel to authorise emergency use of vaccines made by Serum Institute of India, Bharat Biotech and Pfizer, said reports.

The Centre had formed an expert panel to examine the application of emergency vaccine approval by the drug companies.

Serum Institute is manufacturing Covishield developed by Oxford University and Pharma major AstraZeneca while Bharat Biotech is manufacturing Covaxin partnering with Indian Council of Medical Research (ICMR).

Reports said both the firms have made the presentations before the panel but Pfizer is yet to present the data.

Once cleared by the expert panel, the applications will go to the DCGI for approval. An NDTV report said that officials have said the Oxford vaccine is likely to get approval first.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.